GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Total Long-Term Assets

Lionco Pharmaceutical Group Co (SHSE:603669) Total Long-Term Assets : ¥656.8 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Lionco Pharmaceutical Group Co's Total Long-Term Assets for the quarter that ended in Mar. 2025 was ¥656.8 Mil.

Lionco Pharmaceutical Group Co Total Long-Term Assets Historical Data

The historical data trend for Lionco Pharmaceutical Group Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lionco Pharmaceutical Group Co Total Long-Term Assets Chart

Lionco Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 699.76 726.08 723.44 743.03 668.72

Lionco Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 736.44 722.96 710.48 668.72 656.77

Lionco Pharmaceutical Group Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Lionco Pharmaceutical Group Co Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Lionco Pharmaceutical Group Co's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lionco Pharmaceutical Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Total Long-Term Assets
Comparable Companies
SZSE:301089 SHSE:688221 SZSE:301201 SZSE:300016 SZSE:000788 SZSE:300239 SHSE:603538 SHSE:600222 SHSE:688117 SZSE:300636 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 20, National Highway 349, Naidong District, Shannan, CHN
Website
http://www.lingkang.com.cn
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Executives
Zhang Jun Ke Director
Wang Wen Nan Director
Tao Xiao Gang Director
Tao Ling Gang Director
Tao Ling Ping Director

Lionco Pharmaceutical Group Co Headlines

No Headlines